Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy

Murillo-Sanjuán, Laura; Balmaña, J; de Pablo García-Cuenca, A; Lorente Guerrero, J; Uria Oficialdegui, M. L.; Carrasco, E; Diaz de Heredia, Cristina.
Clin. transl. oncol. (Print) ; 24(2): 388-392, febrero 2022.
Artículo en Inglés | IBECS (España) | ID: ibc-203444

Documentos relacionados

  1. Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy.
  2. Characterization of Fanconi Anemia Patients with Head and Neck Squamous Cell Carcinoma: Israel Fanconi Registry.
  3. Oral Premalignant and Malignant Lesions in Fanconi Anemia Patients.
  4. Cutaneous findings in Fanconi anemia.
  5. Ocular Manifestations in Patients with Fanconi Anemia: A Single-Center Experience Including 106 Patients.
  6. Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.
  7. Kidney complications in 107 Fanconi anemia patients submitted to hematopoietic cell transplantation.
  8. Most Fanconi anemia heterozygotes are not at increased cancer risk: A genome-first DiscovEHR cohort population study.
  9. Association of human papillomavirus with Fanconi anemia promotes carcinogenesis in Fanconi anemia patients.
  10. Risk of cancer in heterozygous relatives of patients with Fanconi anemia.